Figure 2
Cumulative incidence (CI) of treatment failure in the 19 patients with cGVHD receiving imatinib. CI was calculated from the start of imatinib to whichever event was considered as treatment failure (intolerance or lack of response).
Cumulative incidence (CI) of treatment failure in the 19 patients with cGVHD receiving imatinib. CI was calculated from the start of imatinib to whichever event was considered as treatment failure (intolerance or lack of response).
